Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63234 1503498110HCLSReviewIndonesiaAugust2017.pdf
Energy Boardroom

AstraZeneca CEO jumps into asset-sale fray to 'focus on what we do well'

24.04.2014 / Fierce Pharma

In announcing first-quarter earnings Thursday, AstraZeneca CEO Pascal Soriot sounded as if he'd been reading the deluge of trend stories analyzing pharma's latest spate of M&A. In fact, he's ready to participate, with a couple of sales/spinoffs together worth about $15 billion, according to analysts

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: